Moreover, tumor formation by human ovarian cancer cells is enhanced by the exogenous expression of pro-HB-EGF, which is blocked by siRNAs for HB-EGF and CRM197, a nontoxic mutant of Dtx. The gene discussed is HBEGF; the disease is ovarian carcinoma.